- Report
- October 2025
- 189 Pages
Global
From €3180EUR$3,545USD£2,797GBP
€3534EUR$3,939USD£3,108GBP
- Report
- October 2025
- 250 Pages
Global
From €4028EUR$4,490USD£3,543GBP
- Report
- March 2025
- 200 Pages
Global
From €4028EUR$4,490USD£3,543GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1077EUR$1,200USD£947GBP
€1346EUR$1,500USD£1,183GBP
- Report
- February 2024
- 70 Pages
India
From €4261EUR$4,750USD£3,748GBP
- Report
- May 2024
- 139 Pages
Global
From €4956EUR$5,524USD£4,359GBP
€5830EUR$6,499USD£5,128GBP
- Report
- November 2020
- 225 Pages
Global
From €13452EUR$14,995USD£11,831GBP
- Report
- November 2025
- 50 Pages
Global
From €2377EUR$2,650USD£2,091GBP
Bromocriptine is a drug used to treat endocrine and metabolic disorders. It is a dopamine agonist, meaning it works by activating dopamine receptors in the body. It is used to treat conditions such as acromegaly, hyperprolactinemia, and type 2 diabetes. It is also used to treat Parkinson's disease and other neurological disorders. Bromocriptine is available in both oral and injectable forms.
Bromocriptine is a widely used drug in the endocrine and metabolic disorders market. It is used to treat a variety of conditions, including acromegaly, hyperprolactinemia, and type 2 diabetes. It is also used to treat Parkinson's disease and other neurological disorders.
Some companies in the Bromocriptine market include Novartis, Pfizer, Merck, and Sanofi. Show Less Read more
